These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6981009)

  • 41. Combined features of pemphigus foliaceus and bullous pemphigoid: immunoblot and immunoelectron microscopic studies.
    Ishiko A; Hashimoto T; Shimizu H; Masunaga T; Nishibori Y; Watanabe K; Nishikawa T
    Arch Dermatol; 1995 Jun; 131(6):732-4. PubMed ID: 7778933
    [No Abstract]   [Full Text] [Related]  

  • 42. [A case of inflammatory vitiligo associated with lupus erythematosus (author's transl)].
    Masutani M; Shoji M; Taneda A; Ogawa H; Miyazaki H
    Nihon Hifuka Gakkai Zasshi; 1975 Aug; 85(9):525-31. PubMed ID: 1081161
    [No Abstract]   [Full Text] [Related]  

  • 43. Assessment of the immune system in 55 Iranian patients with vitiligo.
    Farrokhi S; Hojjat-Farsangi M; Noohpisheh MK; Tahmasbi R; Rezaei N
    J Eur Acad Dermatol Venereol; 2005 Nov; 19(6):706-11. PubMed ID: 16268875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Lymphocyte transformation by melanin antigens in vitiligo vulgaris and malignant melanoma (author's transl)].
    Yamada M; Fujimoto F; Higashi K; Yanase K; Oku T
    Nihon Hifuka Gakkai Zasshi; 1975 May; 85(6):351-8. PubMed ID: 1081153
    [No Abstract]   [Full Text] [Related]  

  • 45. [Reduced phagocytosis of heat-aggregated human IgG by polymorphonuclear leucocytes from patients with systemic lupus erythematosus (author's transl)].
    Ikebe K; Okawa M; Aotsuka S; Yokohari R
    Ryumachi; 1980 Apr; 20(2):75-81. PubMed ID: 7384948
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.
    Kim Y; Vernier RL; Fish AJ; Michael AF
    Lab Invest; 1979 Apr; 40(4):474-80. PubMed ID: 372673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Childhood localized vulvar pemphigoid is a true variant of bullous pemphigoid.
    Saad RW; Domloge-Hultsch N; Yancey KB; Benson PM; James WD
    Arch Dermatol; 1992 Jun; 128(6):807-10. PubMed ID: 1599268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Vitiligo and malignant melanoma (author's transl)].
    Hamm G; Fiedler H
    Dermatol Monatsschr; 1979 Dec; 165(12):838-42. PubMed ID: 546664
    [No Abstract]   [Full Text] [Related]  

  • 50. Vitiligo and polyglandular autoimmune disease with autoantibodies to melanin-producing cells. A new syndrome?
    Peserico A; Rigon F; Semenzato G; Caretto A; Pasini CV; Betterle C
    Arch Dermatol; 1981 Nov; 117(11):751-2. PubMed ID: 7316541
    [No Abstract]   [Full Text] [Related]  

  • 51. [Ultrastructual observations of dendritic cells in the repigmented area of vitiligo: electron microscopic studies on dopa oxidase in melanocytes which are present between the epidermal basal cells in the repigmented area of vitiligo (author's transl)].
    Ito K
    Nihon Hifuka Gakkai Zasshi; 1975 May; 85(6):333-49. PubMed ID: 1081152
    [No Abstract]   [Full Text] [Related]  

  • 52. [Detection of platelet-associated immunoglobulin (IgG) and complement (C3) with immunoperoxidase method and their clinical significance].
    Ogawara H; Murakami H; Tsuchiya J; Kobayashi N; Maekawa T
    Rinsho Byori; 1984 Aug; 32(8):885-9. PubMed ID: 6389941
    [No Abstract]   [Full Text] [Related]  

  • 53. [ELISA for platelet-associated IgG, IgM, and C3, and their clinical application].
    Enokido C; Kawaguchi R; Haruna S; Yonezawa M; Hikiji K; Ishigami T; Takahashi M; Nomura T
    Rinsho Byori; 1989 Aug; 37(8):923-8. PubMed ID: 2585756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Determination of immunoglobulins and complement C3 in the subretinal fluid].
    Ma LQ
    Zhonghua Yan Ke Za Zhi; 1987 Jan; 23(1):27-9. PubMed ID: 3113865
    [No Abstract]   [Full Text] [Related]  

  • 55. Immune mechanisms in vitiligo.
    Bystryn JC
    Immunol Ser; 1989; 46():447-73. PubMed ID: 2488866
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Histochemical and electron microscopic studies of peripheral nerve terminals and clinical studies in vitiligo vulgaris (author's transl)].
    Nozaki T
    Nihon Hifuka Gakkai Zasshi; 1976; 86(1):1-19. PubMed ID: 943623
    [No Abstract]   [Full Text] [Related]  

  • 57. [Chemical vitiligo caused by para-tertiary butyl phenol (author's transl)].
    Yu HS
    Nihon Hifuka Gakkai Zasshi; 1980; 90(12):1129-42. PubMed ID: 6970837
    [No Abstract]   [Full Text] [Related]  

  • 58. Serum antibodies in vitiligo patients.
    Bystryn JC
    Clin Dermatol; 1989; 7(2):136-45. PubMed ID: 2667738
    [No Abstract]   [Full Text] [Related]  

  • 59. [Essential cryoglobulinemia, associated with pseudoleukocytosis (author's transl)].
    Ohta S; Hashimoto Y; Nagataki S; Kosaka K
    Nihon Naika Gakkai Zasshi; 1980 Sep; 69(9):1114-8. PubMed ID: 7430744
    [No Abstract]   [Full Text] [Related]  

  • 60. Vitiligo: a psychologically influenced and influencing disease.
    Hautmann G; Panconesi E
    Clin Dermatol; 1997; 15(6):879-90. PubMed ID: 9404691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.